<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font32 { font-size : 32; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font32">HCV </span>
   <span class="font21">{border-style </span>
   <span class="font20">px;} </span>
   <span class="font19">#ffffff;} </span>
   <span class="font19">RNA </span>
   <span class="font19">lesions </span>
   <span class="font17">hepatitis </span>
   <span class="font16">drug </span>
   <span class="font15">levels </span>
   <span class="font15">skin </span>
   <span class="font15">amlodipine </span>
   <span class="font15">patient </span>
   <span class="font15">ribavirin </span>
   <span class="font15">virus </span>
   <span class="font14">FDE </span>
   <span class="font14">immune </span>
   <span class="font14">px; </span>
   <span class="font14">treatment </span>
   <span class="font14">viral </span>
   <span class="font14">{font-family </span>
   <span class="font14">clinical </span>
   <span class="font14">erythematous </span>
   <span class="font14">font-size </span>
   <span class="font14">patients </span>
   <span class="font14">responses </span>
   <span class="font13">IFN </span>
   <span class="font13">chronic </span>
   <span class="font13">double; </span>
   <span class="font13">fixed </span>
   <span class="font13">infection </span>
   <span class="font13">macules </span>
   <span class="font13">multiple </span>
   <span class="font13">plus </span>
   <span class="font13">reported </span>
   <span class="font13">test </span>
   <span class="font12">Case </span>
   <span class="font12">[]. </span>
   <span class="font12">associated </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">development </span>
   <span class="font12">drugs </span>
   <span class="font12">eruption </span>
   <span class="font12">interferon </span>
   <span class="font12">level </span>
   <span class="font12">results </span>
   <span class="font12">serum </span>
   <span class="font12">sites </span>
   <span class="font12">solid; </span>
   <span class="font12">time </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font12">(Fig. </span>
   <span class="font12">Dermatol() </span>
   <span class="font12">HCV-specific </span>
   <span class="font12">However, </span>
   <span class="font12">PEG-IFNÎ±-b </span>
   <span class="font12">[], </span>
   <span class="font12">atenolol </span>
   <span class="font12">besilate </span>
   <span class="font12">blood </span>
   <span class="font12">bold </span>
   <span class="font12">candesartan </span>
   <span class="font12">challenge </span>
   <span class="font12">correlation </span>
   <span class="font12">courier; </span>
   <span class="font12">course </span>
   <span class="font12">days </span>
   <span class="font12">em; </span>
   <span class="font12">eruptions </span>
   <span class="font12">flares </span>
   <span class="font12">history </span>
   <span class="font12">inverse </span>
   <span class="font12">lichen </span>
   <span class="font12">months </span>
   <span class="font12">parapsoriasis </span>
   <span class="font12">polysensitivity </span>
   <span class="font12">previously </span>
   <span class="font12">pt;} </span>
   <span class="font12">showed </span>
   <span class="font12">therapy </span>
   <span class="font12">transformation </span>
  </p>
 </body>
</html>
